Deka Bank Deutsche Girozentrale Lineage Cell Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$1.12 - $1.61 $450,352 - $647,381	-402,100 Closed	0 $0
Q1 2022 Apr 28, 2022	BUY	$1.21 - $2.48 $44,286 - $90,768	36,600 Added 10.01%	402,100 $607,000
Q4 2021 Feb 02, 2022	SELL	$1.84 - $2.68 $339,480 - $494,460	-184,500 Reduced 33.55%	365,500 $887,000
Q2 2021 Aug 05, 2021	BUY	$2.17 - $3.0 $1.19 Million - $1.65 Million	550,000 New	550,000 $1.59 Million

121

94.2M

63.8K

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $84.9M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.